Trusted News Discovery Since 2008
{{/content}}
Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials
Video Credit: KDKA CBS 2 Pittsburgh
Published on November 16, 2020 - Duration: 00:40s
Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials
Moderna announced Monday that their COVID-19 vaccine candidate is showing 94.5% efficacy; KDKA's Amy Wadas reports.
You are here
Related videos from verified sources
Moderna Applies For Emergency FDA Authorization After Successful Vaccine Trials 02:17
Video credit: CBS 2 New York - Published on November 30, 2020
Moderna's COVID-19 Vaccine - What's Next And Why Masks Will Still Be Needed 01:42
Video credit: WBZ CBS Boston - Published on November 30, 2020
Moderna To Send Its COVID-19 Vaccine To FDA For Emergency Use Authorization 02:28
Video credit: WBZ CBS Boston - Published on November 30, 2020